Navigation Links
Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi
Date:3/3/2008

e health. Gilbert's was founded in 1977 as one of the state's earliest home health operations and is currently one of its largest.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health and related services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix(R), which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-G

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factor
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Gentiva(R) Health Services to Present March 3rd at Raymond James 29th Annual Institutional Investors Conference in Orlando
2. Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
3. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
4. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
5. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
6. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
7. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
8. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
9. Gentiva(R) Health Services Files Universal Shelf Registration Statement
10. Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans
11. In early childhood, continuous care by 1 doctor improves delivery of health screenings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... A cleanroom manufacturing company has ...eanrooms. The feature is a utility panel which ca...nce the cleanroom appearance. , ...Gerbig Engineering, a designer, fabricator and ins...they are now offering a utility panel for integrat...
(Date:7/23/2008)...und,s Commitment to Meet the Financing Needs of Eu...and Institutions--, NEW YORK, July 24 /PRNewswire...n Macleod, Ph.D., has been promoted to Partner. Ba...s responsible for sourcing,evaluating and negotia...rtunities for the Paul Capital Healthcare funds., ...
(Date:7/23/2008)...M, N.C. A study out of Wake Forest University Bap...ctors are correctly identifying patients who are h...aven,t yet confirmed it. , The study used data f...ts with heart attack symptoms who were admitted to...g U.S. centers. , The findings were released to...
(Date:7/23/2008)...d Problem For 10+ Years Even Though Some Kilns Emi...n Cement Kilns in AL, CA, IA,IL, MD, MI, MT, NY, ...wire-USNewswire/ -- For more than a decade,after C...n from cement,kilns across the nation, the U.S. En...e action. Now, a new study from Earthjustice and t...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 2Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 3Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 4Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 5Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 6Health News:Earthjustice/EIP Report: Dangerous Mercury Pollution From Unregulated Cement Kilns in U.S. About Twice as High as Levels Previously Projected by EPA 7
... Health Organization estimates that 40 million peo.../of them in developing countries. In some African ...irus. Last year, an estimated 700,000 children cau...the risk is greatest, researchers have settled on ...
Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack
...ncer survivors can now get up and get moving. Brea... older women, reported higher body esteem and bett...a new study. Researchers compared 40 women who sa...ary women, all early-stage breast cancer survivors...
... took the most antibiotics , or who took the drugs... // developing breast cancer over an average of ab...he drugs, the study showed. Also, since antibiotic...common infections caused by bacteria, some pneumon...
Other Medicine News:Health News:Drug to stop HIV spread to babies may Indirectly harm The Mother 2
(Date:7/22/2008)...dy Demonstrates Feasibility and Efficacy of Treati...Liver Cancer, SAN FRANCISCO, and YONGIN-SI, South...n Francisco, CA and Ottawa, Ontario), and its Sout...y that novel findings from,a Phase I clinical tria...trated that the product was well-tolerated and res...
(Date:7/22/2008)...UTH SAN FRANCISCO, Calif., July 22 /-...it has completed patient enrollment,in its Phase 1...lity and,ammonia scavenging effects of HPN-100 (fo...nylbutyrate) in patients with urea cycle disorders...ults in the fourth quarter,of this year., (Logo: ...
(Date:7/22/2008)...PHIA ANTIPOLIS, France, July 22 /PRNewswire-FirstC...ounced it has successfully completed the,enrollmen...led hypertension,in two clinical pharmacology stud...announced timelines. These trials are designed to ...in comparison to ibuprofen and,naproxen, using the...
(Date:7/21/2008)...W YORK, July 21 /- Ari Kiev, M.D., pr...d speaker at the upcoming conference Wall,Street U...gement,s Guide to,Wall Street. The conference will...Terrace, 267 Fifth Avenue in New York. The event i...nd mid-cap life science companies to gain,better i...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 1Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 2Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 3Breakfast BREAKS and Teen Music Phenomenon the Jonas Brothers Team Up to Raise Awareness about the Importance of Eating Breakfast 12478 4Genta Announces Senior Management Changes 3457 1Genta Announces Senior Management Changes 3457 2Genta Announces Senior Management Changes 3457 3Genta Announces Senior Management Changes 3457 4ThermoGenesis Corp Announces Voluntary Recall of Selected Lots of AXP Bag Sets 3455 1ThermoGenesis Corp Announces Voluntary Recall of Selected Lots of AXP Bag Sets 3455 2Bacteria and nanofilters the future of clean water technology 2295 1Bacteria and nanofilters the future of clean water technology 2295 2
...Survival Benefit in,Liver Cancer -, CHICAGO, June ...e Pharmaceuticals Inc. and Onyx Pharmaceuticals, I...blets significantly,extended overall survival in p...imary liver cancer versus those taking placebo by ...ted at the 43rd,annual meeting of the American Soc...
... - Researchers at,Molecular Insight Pharmaceutical...data on MIP-1072, a radiolabeled, small molecule,m... diagnosis and,staging of prostate cancer at the 5...ine (SNM) in Washington, D.C. MIP-1072 is,one of t...nosis,that Molecular Insight plans to advance into...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4
...rocleix System has added a significant layer of a ...nnovative technologies developed by Gen-Probe incl...plification technique called Transcription-Mediate...ay can simultaneously detect the presence of HIV-1...
...Antibody Test (Reveal Test) is MedMiras flagship r...an serum or plasma against HIV-1 that are produced...eal Test is based on MedMiras proprietary flow-thr...ngle-use test cartridge containing an immunoreacti...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple
X-Hair Trephines
Medicine Products: